PRTA Q3 2023 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$85M+5494.3% YoY

Gross Profit

$27M31.8% margin

Operating Income

$10M12.1% margin

Net Income

$22M25.8% margin

EPS (Diluted)

$0.38

QoQ Revenue Growth

+2011.6%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$9M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$747M

Total Liabilities

$130M

Stockholders' Equity

$617M

Cash & Equivalents

$671M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$85M	$2M	+5494.3%
Gross Profit	$27M	-$38M	+170.3%
Operating Income	$10M	-$50M	+120.5%
Net Income	$22M	-$46M	+147.9%

Revenue Segments

Collaboration

$85M56%

US Rights and Global Rights

$67M44%

Collaboration Program, US Rights

$300,0000%